Now Playing
Feature|Videos|November 19, 2025
The Clarity Gap: The Shift Toward Real-Time, Defensible Decision-Making in Pharma
Author(s)David Edelman, Thrivable
This series kicks off by introducing David Edelman, Founder & CEO of Thrivable, who joins Pharmaceutical Executive to discuss the rising “clarity gap” that is currently putting pharma leaders under pressure.
Advertisement
This episode introduces David Edelman, Founder and CEO of Thrivable, who joins Pharmaceutical Executive to break down why executives are under more scrutiny than ever, why six-week-old reports and social chatter no longer cut it, and how AI-powered, real-time patient intelligence is transforming leadership from reactive guessing to confident, defensible decision-making.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
The Importance of Suppressor Cells in Tumor Progression
2
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
3
How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy
4
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer
5
